The current edition of the British Journal of Psychiatry, May 2018, contains academic papers on depressive disorders. In this post I will share some of the declarations of interest linked … Continue reading The British Journal of Psychiatry: are competing interests of authors sufficiently transparent?
With careful thought, and backed with full supporting evidence, I sent the following letter of the 2nd February 2016 to support my petition for a Sunshine Act for Scotland. The Senior Clerk … Continue reading A letter that the Scottish Parliament felt unable to publish
In my last post I considered the level of transparency provided by the British Association for Psychopharmacology (BAP) in relation to its recently published Guidelines on prescribing for depressive disorders. … Continue reading Stephen Stahl: $3,581,159 in payments from Pharma
The above Evidence-based guidelines for treating depressive disorders with antidepressants have recently been published. The British Association for Psychopharmacology are an organisation highly regarded by my profession of psychiatry. 12% of their … Continue reading British Association for Psychopharmacology Guidelines (BAP)